Search bioRxiv⌕ Search

Biology subjects

Metanat, S.

Publications and source records attributed to Metanat, S..

2 recordsLinked to original sources

The antiviral Interferon pathway drives astrocyte aging and motor decline

Aging encompasses low-level inflammation and motor decline. Astrocytes are neuroregulatory glial cells that change in aging, particularly in the cerebellum, which is essential for movement coordination. Regulation and functionality of cerebellar astrocytes in aging is unknown. We show that antiviral type I Interferons (IFN-I) drive motor deficits and regional astrocyte aging. Transcriptomics reveal that cerebellar astrocytes, but not cortical, exhibit an antiviral state that intensifies with age, with increased expression of Stat1. Aged mice display motor deficits similar to humans that improve after peripheral IFN-I receptor neutralization, whereas astrocyte Stat1 induces motor deficits during chronic inflammation in adults. While strong systemic inflammation induces astrocyte antiviral state, in aging, chromatin de-repression of Stat1 and nucleotide sensors in cerebellar astrocytes amplifies local IFN-I signaling. We identify functional interaction between a classical immune pathway and astrocytes, representing an actionable strategy to preserve motor function in aging.

neuroscience↗

Astrocyte transcriptomic analysis identifies glypican 5 downregulation as a contributor to synaptic dysfunction in Alzheimer disease models

Synaptic dysfunction is an early feature in Alzheimers disease (AD) and correlates with cognitive decline. Astrocytes are essential regulators of synapses, impacting synapse formation, maturation, elimination and function. To understand if synapse-supportive functions of astrocytes are altered in AD, we used astrocyte BacTRAP mice to generate a comprehensive dataset of hippocampal astrocyte transcriptional alterations in two mouse models of Alzheimers pathology (APPswe/PS1dE9 and Tau P301S), characterizing sex and age-dependent changes. We found that astrocytes from both models downregulate genes important for synapse regulation and function such as the synapse-maturation factor Glypican 5. This transcriptional signature is shared with human post-mortem AD patients. Manipulating a key component of this signature by in vivo overexpression of Glypican 5 in astrocytes is sufficient to prevent early synaptic dysfunction and improve spatial learning in APPswe/PS1dE9 mice. These findings open new avenues to target astrocytic factors to mitigate AD synaptic dysfunction.

neuroscience↗